Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

The role of antenatal inflammation in the genesis of retinal and sub-retinal vasculopathy of the offspring

EF 2016-17

Résumé
Preterm birth (PTB) designates delivery before the 37th week of gestation. It affects 1 child out of 10 and is often accompanied by morbidities having long lasting consequences. Retinopathy of Prematurity (ROP) is one of them and it affects 1 preterm infant out of 5. This pathology is a default in the normal proliferation of retinal blood vessels and can cause blindness. High oxygen concentration and retinal inflammation are the principal triggers of this condition defined by 2 stages: 1) vaso-obliteration, the stopping of vessels growth; 2) neovascularisation, the vessels start growing again and are characterized by anarchic sprouting and vessel tortuosity; it finally causes retinal detachment and blindness. The pro-inflammatory cytokine interleukin (IL)-1 is a principal mediator in the molecular cascade leading to preterm birth. It sets off a deleterious inflammatory reaction in the uterus in response to infection or other pathology. The goal of this study is to counteract the action of IL-1 by blocking its receptor, IL-1R, and therefore prevent the development of ROP. Such an antagonist was developed in the host laboratory and showed great efficacy in stopping preterm birth. We therefore use it pre-natively on a pre-clinical model in order to protect the retina from foeto-maternal inflammation and reduce the risk of ROP in the infant.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367053
Name
Beaudry-Richard Alexandra
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of antenatal inflammation in the genesis of retinal and sub-retinal vasculopathy of the offspring
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenèse; Choroïde; Inflammation; Interleukine-1; Ophtalmologie; Prématurité; Périnatalité; Rétine; Rétinopathie; Système Visuel
Abstract
Preterm birth (PTB) designates delivery before the 37th week of gestation. It affects 1 child out of 10 and is often accompanied by morbidities having long lasting consequences. Retinopathy of Prematurity (ROP) is one of them and it affects 1 preterm infant out of 5. This pathology is a default in the normal proliferation of retinal blood vessels and can cause blindness. High oxygen concentration and retinal inflammation are the principal triggers of this condition defined by 2 stages: 1) vaso-obliteration, the stopping of vessels growth; 2) neovascularisation, the vessels start growing again and are characterized by anarchic sprouting and vessel tortuosity; it finally causes retinal detachment and blindness. The pro-inflammatory cytokine interleukin (IL)-1 is a principal mediator in the molecular cascade leading to preterm birth. It sets off a deleterious inflammatory reaction in the uterus in response to infection or other pathology. The goal of this study is to counteract the action of IL-1 by blocking its receptor, IL-1R, and therefore prevent the development of ROP. Such an antagonist was developed in the host laboratory and showed great efficacy in stopping preterm birth. We therefore use it pre-natively on a pre-clinical model in order to protect the retina from foeto-maternal inflammation and reduce the risk of ROP in the infant.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Beaudry-Richard, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~